Book Image

Live Longer with AI

By : Tina Woods
Book Image

Live Longer with AI

By: Tina Woods

Overview of this book

Live Longer with AI examines how the latest cutting-edge developments are helping us to live longer, healthier and better too. It compels us to stop thinking that health is about treating disease and start regarding it as our greatest personal and societal asset to protect. The book discusses the impact that AI has on understanding the cellular basis of aging and how our genes are influenced by our environment – with the pandemic highlighting the interconnectedness of human and planetary health. Author Tina Woods, founder and CEO of Collider Health and Collider Science, and the co-founder of Longevity International, has curated a panel of deeply insightful interviews with some of today’s brightest and most innovative thought leaders at the crossroads of health, technology and society. Read what leading experts in health and technology are saying about the book: "This is a handbook for the revolution!" —Sir Muir Gray, Director, Optimal Ageing "You can live longer and be happier if you make some changes – that is the theme of this book. Well-written and compelling." —Ben Page, CEO, Ipsos Mori "Tina's book is a must-read for those who want to discover the future of health." —José Luis Cordeiro, Fellow, World Academy of Art & Science; Director, The Millennium Project; Vice Chair, Humanity Plus; Co- Author of The Death of Death About the consultant editor Melissa Ream is a leading health and care strategist in the UK, leveraging user-driven design and artificial intelligence to design systems and support people to live healthier, longer lives.
Table of Contents (8 chapters)
Preface
7
Index

Healthy Longevity Globally

Turning to diseases of aging, how can we utilize global data sharing to fast-track research and achieve healthy longevity all over the world? The Global Future Council (GFC) on Human Enhancement and Longevity considers global data sharing as 1 of 4 critical workstreams. One model of best practice exists already[75]: the Alzheimer's Disease Neuroimaging Initiative (ADNI)[76] project, which has strict rules designed to encourage sharing of collected data among its members including both public and private research institutions. To address GDPR challenges new approaches to consent management[77] or dynamic consent[78] are being trialed in the UK and EU and by global organizations including Global Alliance for Genomics and Health (GA4GH).

Recently, the US National Academy for Medicine (NAM) announced the Global Roadmap for Healthy Longevity Grand Challenge[79], backed with $35 million in funding. It is an international, independent, and multidisciplinary...